Skip to main content

VASO Corp

corporate_fare Company Profile

VASO Corp

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed healthcare software solutions, including diagnostic imaging applications; managed network infrastructure, such as routers, switches, and other equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Exchange: OTCSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed VASO - Latest Insights

VASO
Apr 16, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
VASO
Apr 10, 2026, 9:29 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
VASO
Mar 31, 2026, 5:25 PM EDT
Filing Type: 10-K
Importance Score:
7
VASO
Mar 31, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
VASO
Feb 12, 2026, 3:20 PM EST
Filing Type: 8-K
Importance Score:
7